Chester County News and Community Website
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the approval of inducement awards to Braden Parker, who recently joined the company as Chief Commercial Officer on September 24, 2024. These …
Savara Inc. Grants Inducement Awards to New Chief Commercial Officer Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has unveiled the Savara Early Access Program, a significant initiative aimed at providing molgramostim to patients suffering from autoimmune pulmonary alveolar proteinosis (aPAP). This …
Savara Inc. Launches Early Access Program for Rare Lung Disease Treatment Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the appointment of Braden Parker as Chief Commercial Officer, effective immediately. Parker brings over 25 years of experience in the healthcare and …
Savara Inc. Appoints Braden Parker as Chief Commercial Officer Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the issuance of inducement awards to a new team member, aligning with the company’s strategic growth initiatives.
Savara Inc. Grants Inducement Awards to New Employee Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has released its financial results for the second quarter ending June 30, 2024, alongside significant business updates that highlight the company’s progress in clinical …
Savara Inc. Reports Strong Q2 2024 Results and Positive IMPALA-2 Trial Outcomes Read More
LANGHORNE, PA — In a significant advancement for patients suffering from autoimmune Pulmonary Alveolar Proteinosis (aPAP), Savara Inc. has revealed promising outcomes from its IMPALA-2 Phase 3 clinical trial. The …
Savara Inc. Announces Breakthrough in aPAP Treatment with IMPALA-2 Trial Success Read More LANGHORNE, PA — Biopharmaceutical company Savara Inc. (Nasdaq: SVRA) disclosed its financial outcomes for the first quarter ended March 31, 2024, while casting an optimistic glance towards its pipeline’s progress …
Savara Inc. Eyes Future Growth with Ongoing IMPALA-2 Trial and Strategic Investments Read More